Serine proteases as luminal mediators of intestinal barrier dysfunction and symptom severity in IBS
Shoko Edogawa(Mayo Clinic), Madhusudan Grover(Mayo Clinic), Stéphanie Peters(Mayo Clinic in Arizona), Wendy Sundt(Mayo Clinic), Lakshmikanth L. Chikkamenahalli(Mayo Clinic), Rondell P. Graham(Mayo Clinic in Arizona), Roy B. Dyer(Mayo Clinic), Adam Edwinson(Mayo Clinic in Arizona), Margaret K. Breen‐Lyles, Purna Kashyap(Mayo Clinic), Stephen Johnson(Mayo Clinic), Gianrico Farrugia(Mayo Clinic), Sara I. Graves(Mayo Clinic in Florida), Jun Chen(University of Pennsylvania), Sakteesh Gurunathan(Icahn School of Medicine at Mount Sinai)
Cited by 102
Related Papers
Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis
|Nature Medicine|2013|4.4k
Gut microbes promote colonic serotonin production through an effect of short‐chain fatty acids on enterochromaffin cells
|The FASEB Journal|2014|1.3k
Associating microbiome composition with environmental covariates using generalized UniFrac distances
|Bioinformatics|2012|1.3k
Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens
|Nature|2013|1.1k
Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls
|Scientific Reports|2016|973